Discriminated effects of thiolated chitosan-coated pMMA paclitaxel-loaded nanoparticles on different normal and cancer cell lines

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 6, Issue 5, 2010, Pages 689-697

  Akhlaghi, Seyedeh Parinaz ^a   Saremi, Shahrooz ^a   Ostad, Seyed Nasser ^a   Dinarvand, Rassoul ^a,b   Atyabi, Fatemeh ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cytotoxicity; Nanoparticles; Paclitaxel; Poly(methyl methacrylate); Thiolated chitosan

Indexed keywords

AMMONIUM NITRATE; ANTICANCER DRUG; BREAST CARCINOMA CELLS; CANCER CELL LINES; COLON CELLS; ENCAPSULATION EFFICIENCY; GLUTATHIONE CONJUGATES; IN-VITRO; PACLITAXEL; POSITIVE CHARGES; RADICAL POLYMERIZATION; SIZE RANGES; THIOLATED CHITOSAN;

ACRYLIC MONOMERS; AMMONIUM COMPOUNDS; CELL CULTURE; CERIUM; CHITIN; CHITOSAN; CYTOTOXICITY; ENCAPSULATION; ESTERS; HYDROGELS;

NANOPARTICLES;

AMMONIUM NITRATE; CERIUM; CHITOSAN; GLUTATHIONE; PACLITAXEL; POLY(METHYL METHACRYLATE); THIOL;

ARTICLE; BIOCOMPATIBILITY; BREAST CARCINOMA; CANCER CELL; CANCER CELL CULTURE; CONJUGATION; CONTROLLED STUDY; CYTOTOXICITY; DEPOLYMERIZATION; DRUG RELEASE; DRUG SYNTHESIS; ENCAPSULATION; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; CHITOSAN; DRUG CARRIERS; HUMANS; MICE; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; NIH 3T3 CELLS; PACLITAXEL; POLYMETHYL METHACRYLATE;

EID: 77957155414     PISSN: 15499634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nano.2010.01.011     Document Type: Article

References (30)

1. Spencer C.M., Faulds D. Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer. Drugs 1994, 48:794-847.
2. Rowinsky E.K., Donehower R.C. Paclitaxel (Taxol). N Engl J Med 1995, 333:75-81.
3. Schiff P., Fant J., Horwitz S.B. Promotion of microtubule assembly in vitro by Taxol. Nature 1979, 277:665-667.
4. Koziaraa J.M., Lockmanb P.R., Allenb D.D., Mumper R.J. Paclitaxel nanoparticles for the potential treatment of brain tumors. J Control Release 2004, 99:259-269.
5. Tarr B.D., Yalkowsky S.H. A new parenteral vehicle for the administration of some poorly soluble anti-cancer drugs. Parenter Sci Technol 1987, 41:31-33.
6. Danhier F., Lecouturier N., Vroman B., Jerome C., Marchand-Brynaert J., Feron O., et al. Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation. J Control Release 2009, 133:11-17.
7. Singla K., Garg A., Aggarwal D. Paclitaxel and its formulations. Int J Pharm 2002, 235:179-192.
8. Leroux J.C., Doelker E., Gurny R. The use o obtained f drug-loaded nanoparticles in cancer chemotherapy. Microencapsulation 1996, 535-575. Marcel Dekker, New York. S. Benita (Ed.).
9. Thanou M., Verhoef J., Junginger H. Oral drug absorption enhancement by chitosan and its derivatives. Adv Drug Deliv Rev 2001, 52:117-126.
10. Aghaei Moghaddam F., Atyabi F., Dinarvand R. Preparation and in vitro evaluation of mucoadhesion and permeation enhancement of thiolated chitosan-pHEMA core-shell nanoparticles. Nanomedicine 2009, 5:208-215.
11. Lemarchand C., Gref R., Couvreur P. Polysaccharide-decorated nanoparticles. Eur J Pharm Biopharm 2004, 58:327-341.
12. Bernkop-Schnurch A., Kast C.E. Chemically modified chitosans as enzyme inhibitors. Adv Drug Deliv Rev 2001, 52:127-137.
13. Bernkop-Schnurch A. Thiomers: a new generation of mucoadhesive polymers. Adv Drug Deliv Rev 2005, 57:1569-1582.
14. Atyabi F., Talaie F., Dinarvand R. Thiolated chitosan nanoparticles as an oral delivery system for Amikacin: in vitro and ex vivo evaluations. J Nanosci Nanotechnol 2009, 9:4593-4603.
15. Bernkop-Schnurch A., Kast C.E., Guggi D. Permeation enhancing polymers in oral delivery of hydrophilic macromolecules: thiomer/GSH systems. J Control Release 2003, 93:95-103.
16. Atyabi F., Aghaie Moghaddam F., Dinarvand R., Zohuriaan-Mehr M.J., Ponchel G. Thiolated chitosan coated poly hydroxyethyl methacrylate nanoparticles: synthesis and characterization. Carbohydr Polym 2008, 74:59-67.
17. Chauvierre C., Labarre D., Couvreur P., Vauthier C. Radical polymerisation of alkylcyanoacrylates initiated by the redox system dextran-cerium (IV) under acidic aqueous conditions. Macromolecules 2003, 36:6018-6027.
18. Atyabi F., Majzoob S., Dorkoosh F., Sayyah M., Ponchel G. The impact of trimethyl chitosan on in vitro mucoadhesive properties of pectinate beads along different sections of gastrointestinal tract. Drug Dev Ind Pharm 2007, 33:291-300.
19. He P., Davis S.S., Illum L. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int J Pharm 1998, 166:68-75.
20. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
21. Bravo-Osuna I., Vauthier C., Farabollini A., Palmieri G.F., Ponchel G. Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles. Biomaterials 2007, 28:2233-2243.
22. Bravo-Osuna I., Schmitz T., Bernkop-Schnurch A., Vauthier C.F., Ponchel G. Elaboration and characterization of thiolated chitosan-coated acrylic nanoparticles. Int J Pharm 2006, 316:170-175.
23. Huang M., Khor E., Lim L.Y. Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation. Pharm Res 2004, 21:344-356.
24. Kafedjiiski K., Foge F., Werle M., Bernkop-Schnurch A. Synthesis and in vitro evaluation of a novel chitosan-glutathione conjugate. Pharm Res 2005, 22:1480-1488.
25. Bilicic M.B., Filipovic-Grcic J., Martinac A., Barbaric M., Zorc B., Cetina-Cizmek B., et al. Synthesis and characterization of thiomers of polyaspartamide type. Int J Pharm 2005, 291:211-219.
26. Feng S.S., Mei L., Anitha P., Gan C.W., Zhou W. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel. Biomaterials 2009, 30:3297-3306.
27. Win K.Y., Feng S.S. Effects of particle size and surface coating on cellular uptake of polyeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 2005, 26:2713-2722.
28. He M., Zhao Z., Yin L., Tang C., Yin C. Hyaluronic acid cotaed poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers. Int J Pharm 2009, 373:165-173.
29. Pauillard V., Nicolaou A., Double J.A., Philips R.M. Methionine dependence of tumours: a biochemical strategy for optimizing paclitaxel chemosensitivity in vitro. Biochem Pharmacol 2006, 71:772-778.
30. Bakogeorgoua E., Hatzogloub A., Castanasc E. Taxol inhibits opioid binding on T47D human breast cancer cells. Biochem Biophys Res Commun 1997, 235:201-204.